Intellia Therapeutics, Inc.(NTLA)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
NTLA | 1.59 B | -3.23x | -9.50% | - | $-3.52 | -56.34% | 0.13 | - | $28.25 | $7.95 |
RARE | 2.88 B | -4.80x | -2.20% | -90.90% | $-6.10 | - | - | - | $42.37 | $18.29 |
IMNM | 2.53 B | -9.34x | - | - | $-2.39 | -50.14% | 0.63 | - | $27.65 | $7.96 |
BCRX | 2.36 B | -5.25x | 7.50% | -51.71% | $-1.77 | - | - | - | $10.94 | $6.00 |
VRDN | 1.99 B | -5.38x | 95.80% | - | $-3.35 | -58.14% | 8.39 | - | $34.29 | $13.18 |
Peer Valuation & Performance Analysis
Peer group analysis for Intellia Therapeutics, Inc. (NTLA) compared to its primary competitors (including RARE, IMNM, BCRX) reveals distinct metrics. NTLA trades at a valuation premium compared to its competitors, with a P/E ratio of -3.2x versus the peer average of -6.2x (representing a -48% premium). This indicates that the market expects superior growth or commands a quality premium for NTLA. In terms of growth, NTLA's revenue growth of -9.5% lags behind the peer average of 33.7%, indicating potential market share losses or slower industry adoption.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
β’ NTLA ranks #0 in P/E ratio, #5 in revenue growth, and #1 in profit margins
β’ Average ranking: #2 - π― Top-tier fundamentals relative to peer group
β’ Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-07-17 | $11.73 | $11.84 | $11.35 | $11.38 | 4,325,700 | -3.03% |
| 2026-07-16 | $12.43 | $12.59 | $11.65 | $11.86 | 6,531,700 | -4.59% |
| 2026-07-15 | $13.13 | $13.38 | $12.88 | $13.04 | 3,923,994 | -0.69% |
| 2026-07-14 | $13.31 | $13.57 | $13.00 | $13.30 | 4,053,600 | -0.08% |
| 2026-07-13 | $13.76 | $13.77 | $12.77 | $13.02 | 7,475,000 | -5.38% |
| 2026-07-10 | $15.44 | $15.44 | $14.10 | $14.21 | 6,171,200 | -7.93% |
| 2026-07-09 | $16.59 | $17.16 | $15.14 | $15.44 | 7,380,100 | -6.93% |
| 2026-07-08 | $16.81 | $17.09 | $16.35 | $16.84 | 3,546,200 | +0.18% |
| 2026-07-07 | $17.85 | $18.11 | $16.85 | $17.43 | 3,170,100 | -2.35% |
| 2026-07-06 | $17.33 | $18.08 | $16.17 | $17.84 | 3,841,300 | +2.94% |
| 2026-07-02 | $17.63 | $18.48 | $17.30 | $17.56 | 4,165,300 | -0.40% |
| 2026-07-01 | $16.78 | $17.83 | $16.72 | $17.24 | 3,730,800 | +2.74% |
| 2026-06-30 | $16.58 | $16.95 | $16.00 | $16.92 | 3,800,600 | +2.05% |
| 2026-06-29 | $16.67 | $17.18 | $15.94 | $16.61 | 5,575,000 | -0.36% |
| 2026-06-26 | $15.75 | $16.96 | $15.67 | $16.68 | 9,813,200 | +5.90% |